Vanguard Capital Management’s Kairos Pharma KAPA Stock Holding History
Bought
Maintained
Sold
Other funds holding KAPA
Vanguard Capital Management's KAPA Position: Q3 2026 in Review
Vanguard Capital Management reduced its Kairos Pharma (KAPA) stake by 71% in Q3 2026, selling an estimated $48.7K and leaving 9,707 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4001.
Vanguard Capital Management first reported a position in KAPA in Q1 2026 and has held it in 3 quarters since. The position peaked at $130K in Q1 2026. 5 funds tracked by Wall St. Rank hold KAPA as of Q3 2026.
- Vanguard Capital Management held 9,707 shares of Kairos Pharma worth $15.9K as of Q3 2026.
- Vanguard Capital Management sold 23,418 Kairos Pharma shares in Q3 2026, an estimated $48.7K.
- Kairos Pharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #4001 holding.
- Vanguard Capital Management first reported a position in Kairos Pharma in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Kairos Pharma position peaked at $130K in Q1 2026.
- 5 funds tracked by Wall St. Rank held Kairos Pharma as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.